A. Wehmeier

994 total citations
31 papers, 591 citations indexed

About

A. Wehmeier is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, A. Wehmeier has authored 31 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 14 papers in Hematology and 6 papers in Molecular Biology. Recurrent topics in A. Wehmeier's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Platelet Disorders and Treatments (6 papers) and Multiple Myeloma Research and Treatments (5 papers). A. Wehmeier is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Platelet Disorders and Treatments (6 papers) and Multiple Myeloma Research and Treatments (5 papers). A. Wehmeier collaborates with scholars based in Germany, United Kingdom and South Sudan. A. Wehmeier's co-authors include Wolfgang Schneider, G. V. R. Born, M. Arning, K. O. Kliche, Irene Daum, Thomas Südhoff, Rüdiger E. Scharf, W. Schneider, H K Nieuwenhuis and Claudia Menzel and has published in prestigious journals such as Nature, Journal of the American Academy of Dermatology and Leukemia.

In The Last Decade

A. Wehmeier

29 papers receiving 568 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Wehmeier Germany	11	259	235	112	98	79	31	591
I. J. Temperley Ireland	13	269 1.0×	236 1.0×	122 1.1×	78 0.8×	39 0.5×	56	766
Fumihiko Monma Japan	13	317 1.2×	120 0.5×	112 1.0×	50 0.5×	70 0.9×	35	496
Renée V. Gardner United States	16	311 1.2×	220 0.9×	110 1.0×	59 0.6×	42 0.5×	45	663
Kiat Hoe Ong Singapore	14	210 0.8×	199 0.8×	179 1.6×	56 0.6×	182 2.3×	35	720
Deniz Yılmaz Karapınar Türkiye	16	286 1.1×	92 0.4×	82 0.7×	51 0.5×	103 1.3×	70	656
Geetha Narayanan India	9	129 0.5×	99 0.4×	79 0.7×	70 0.7×	37 0.5×	62	482
N. Duédari France	18	734 2.8×	165 0.7×	84 0.8×	40 0.4×	45 0.6×	47	1.1k
Prantar Chakrabarti India	15	216 0.8×	140 0.6×	74 0.7×	27 0.3×	42 0.5×	53	479
L Konopka Poland	16	241 0.9×	591 2.5×	93 0.8×	39 0.4×	57 0.7×	56	961
Dennis A. Casciato United States	10	117 0.5×	53 0.2×	65 0.6×	59 0.6×	45 0.6×	20	489

Countries citing papers authored by A. Wehmeier

Since Specialization

Citations

This map shows the geographic impact of A. Wehmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Wehmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Wehmeier more than expected).

Fields of papers citing papers by A. Wehmeier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Wehmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Wehmeier. The network helps show where A. Wehmeier may publish in the future.

Co-authorship network of co-authors of A. Wehmeier

This figure shows the co-authorship network connecting the top 25 collaborators of A. Wehmeier. A scholar is included among the top collaborators of A. Wehmeier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Wehmeier. A. Wehmeier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schneider, W. Joel & A. Wehmeier. (2008). Unklares Fieber und colchicinsensible Amyloidose: Familiäres Mittelmeerfieber?. DMW - Deutsche Medizinische Wochenschrift. 114(24). 951–954.

Weber, G., et al.. (2004). Ultratrace voltammetric determination of DNA-bound platinum in patients after administration of oxaliplatin. Analytical and Bioanalytical Chemistry. 380(1). 54–8. 22 indexed citations

Wehmeier, A., et al.. (2003). Primary non-Hodgkin's lymphoma of bone: three cases and a short review of the literature. Annals of Hematology. 82(7). 440–443. 12 indexed citations

Wehmeier, A., et al.. (2002). Interindividual differences in oxaliplatin pharmacokinetics. International Journal of Clinical Pharmacology and Therapeutics. 40(12). 569–570. 2 indexed citations

Heyll, A., Ulrich Germing, A. Wehmeier, et al.. (1998). Dyshematopoiesis in De Novo Acute Myeloid Leukemia: Cell Biological Features and Prognostic Significance. Leukemia & lymphoma. 29(5-6). 523–531. 5 indexed citations

Heyll, A., D. Söhngen, Guido Kobbe, et al.. (1997). Idarubicin, melphalan and cyclophosphamide: an intensified high-dose regimen for the treatment of myeloma patients.. PubMed. 11 Suppl 5. S32–4. 7 indexed citations

Giagounidis, Aristoteles, Sebastian Flacke, M. Burk, et al.. (1997). Pseudomonas aeruginosa blepharoconjunctivitis during cytoreductive chemotherapy in a woman with acute lymphocytic leukemia. Annals of Hematology. 75(3). 121–123. 10 indexed citations

Südhoff, T, et al.. (1997). Increases of sICAM-1 during neutropenic pneumonia in leukemic patients. Leukemia. 11(3). 346–351. 10 indexed citations

Wehmeier, A., Hans E. Schaefer, Barbara Hildebrandt, et al.. (1997). Lymphoid Myelofibrosis Associated with High Grade B Cell Lymphoma of the Liver: Morphological, Cytogenetic, and Clinical Features. Leukemia & lymphoma. 26(1-2). 197–204. 3 indexed citations

10.

Wehmeier, A., et al.. (1997). Relation of Platelet Abnormalities to Thrombosis and Hemorrhage in Chronic Myeloproliferative Disorders. Seminars in Thrombosis and Hemostasis. 23(4). 391–402. 52 indexed citations

11.

Péus, Dominik, S. von Schmiedeberg, A. Pier, et al.. (1996). Coagulation factor V gene mutation associated with activated protein C resistance leading to recurrent thrombosis, leg ulcers, and lymphedema: successful treatment with intermittent compression. Journal of the American Academy of Dermatology. 35(2). 306–309. 8 indexed citations

12.

Arning, M., et al.. (1995). Infusion‐related toxicity of three different amphotericin B formulations and its relation to cytokine plasma levels. Mycoses. 38(11-12). 459–465. 86 indexed citations

13.

Arning, M., et al.. (1995). Neutrophilic dermal infiltrates in granulocytopenic patients with acute leukemia. Annals of Hematology. 71(5). 257–261. 6 indexed citations

14.

Arning, M., et al.. (1995). Neutrophilic dermal infiltrates in granulocytopenic patients with acute leukemia. Annals of Hematology. 71(5). 257–261. 1 indexed citations

15.

Söhngen, D., A. Wehmeier, Christof Specker, & Wolfgang Schneider. (1994). Antiphospholipid Antibodies in Systemic Lupus Erythematosus and Sneddon's Syndrome. Seminars in Thrombosis and Hemostasis. 20(1). 55–63. 10 indexed citations

16.

Wehmeier, A., et al.. (1991). Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. Annals of Hematology. 63(2). 101–106. 85 indexed citations

17.

Wehmeier, A., Diethelm Tschöpe, Jennifer S. Esser, et al.. (1991). Circulating activated platelets in myeloproliferative disorders. Thrombosis Research. 61(3). 271–278. 48 indexed citations

18.

Wehmeier, A., R Scharf, & W Schneider. (1990). Influence of splenectomy on platelet morphometry and function. Journal of Molecular Medicine. 68(17). 847–852. 9 indexed citations

19.

Wehmeier, A. & W Schneider. (1989). Platelet volume parameters as a diagnostic tool: The influence of anticoagulation and storage conditions on platelet impedance volume. Journal of Molecular Medicine. 67(19). 980–984. 8 indexed citations

20.

Born, G. V. R. & A. Wehmeier. (1980). Possible Approaches to the Pharmacological Prevention of Myocardial Ischaemia. Acta Medica Scandinavica. 208(S642). 191–194. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact